ClinicalTrials.govpublic full text
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection
hepatitis c, 7977, gs-7977, psi-7977, sofosbuvir (sof), pegylated interferon (peg-ifn), ribavirin (rbv), interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 909419
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.